Gene · 887
Papers2,046
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,046
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Neuronal Cholecystokinin Receptor: An Emerging Therapeutic Target for Ameliorating Neurological Diseases. | Mol Neurobiol | 2025 | 41398125 | PubTator, text mining | PubMed |
| Discovery of a β-arrestin-biased CCKBR agonist that blocks CCKBR-dependent long-term potentiation. | Nat Commun | 2025 | 41360797 | PubTator, text mining | PubMed |
| Gastrin signaling in cardiovascular pathophysiology: From molecular crosstalk to clinical implications. | Clin Exp Hypertens | 2025 | 41261901 | PubTator, text mining | PubMed |
| The Autoimmune Gastritis Puzzle: Emerging Cellular Crosstalk and Molecular Pathways Driving Parietal Cell Loss and ECL Cell Hyperplasia. | Cells | 2025 | 41148791 | PubTator, text mining | PubMed |
| Cholesterol residence time drives regulation of the G protein-coupled cholecystokinin receptor. | Mol Pharmacol | 2025 | 41039689 | PubTator, text mining | PubMed |
| Advances in radiopharmaceuticals for cancer radiotheranostics: CCK2R targeting as a paradigm for translational innovation. | Cancer Commun (Lond) | 2025 | 40974551 | PubTator, text mining | PubMed |
| Dimeric CCK2R radiotheranostic tracers synergize with mTOR inhibition for enhanced tumor therapy. | Theranostics | 2025 | 40963930 | PubTator, text mining | PubMed |
| Diagnostic Performance of the 68Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors. | J Nucl Med | 2025 | 40876951 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| C-Myc Overexpression in Adolescent and Young Adult Breast Cancer: Distinct From Older Adults With Relevantly Expressed Cholecystokinin B Receptor. | Pathol Int | 2025 | 40855909 | PubTator, text mining | PubMed |
| Increased reflux secondary bile acids are associated with changes to the microbiome and transcriptome in Barrett's esophagus. | Gut Microbes | 2025 | 40844321 | PubTator, text mining | PubMed |
| Evolution of the Jawed Vertebrate (Gnathostomata) Stomach Through Gene Repertoire Loss: Findings from Agastric Species. | J Dev Biol | 2025 | 40843895 | PubTator, text mining | PubMed |
| Calcitonin and procalcitonin measurement after cholecystokinin-2/gastrin receptor agonist stimulation in patients with advanced medullary thyroid cancer: results from the GRAN-T-MTC study. | Endokrynol Pol | 2025 | 40586407 | PubTator, text mining | PubMed |
| The central signaling pathways related to metabolism-regulating hormones of the gut-brain axis: a review. | J Transl Med | 2025 | 40500780 | PubTator, text mining | PubMed |
| The central role of gastrin in Helicobacter pylori gastric carcinogenesis. | Scand J Gastroenterol | 2025 | 40411354 | PubTator, text mining | PubMed |
| Current and Near-Future Technologies to Quantify Nanoparticle Therapeutic Loading Efficiency and Surface Coating Efficiency with Targeted Moieties. | Bioengineering (Basel) | 2025 | 40281721 | PubTator, text mining | PubMed |
| Target-Specific Locked Nucleic Acid Gapmer Decreases Growth and Metastases of Pancreatic Cancer. | Mol Cancer Ther | 2025 | 40177867 | PubTator, text mining | PubMed |
| Bayesian Nonparametric Analysis of Residence Times for Protein-Lipid Interactions in Molecular Dynamics Simulations. | J Chem Theory Comput | 2025 | 40172093 | PubTator, text mining | PubMed |
| Addendum: Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue. | Oncotarget | 2025 | 40042992 | PubTator, text mining | PubMed |
| Gastrointestinal cholecystokinin signaling pathway drugs modulate osteogenic/cementogenic differentiation of human periodontal ligament stem cells. | J Dent | 2025 | 40032153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/887/papers?page=2